Corporate Message

Dear reader,

Thank you for your interest in Sofpromed.

We have become a trusted, oncology-focused Contract Research Organization (CRO) since we began our business activities in 2012. During this period, we have provided both commercial and academic sponsors with exceptional clinical trial management services.

In recent years, we have experienced an exciting growth and we have further extended our clinical operations within Europe. Currently, we have a growing list of more than 30 ongoing cancer studies under management with multiple European and US-based sponsors.

Our customers value our regulatory and technical proficiency in European territory, as well as our oncological expertise. They benefit from our highly skilled staff exclusively specialized in managing cancer clinical trials and our GCP-based quality system devoted to anticipated problem prevention and continuous improvement. We act with integrity, honesty, and determination to achieve project goals, in agreed timelines and budget.

In 2019, we will continue working on optimizing our clinical trial management services across Europe to accelerate study start-up, recruitment, and data analysis. At the same time, we seek to further inject our proactive, client-centered philosophy in all we do. Improved customer service, care, and experience is at the heart of our corporate values.

We look forward to working with you and achieving success in your cancer drug development programs.

Patricio Ledesma

President and CEO

Pin It on Pinterest

Share This